Tirzepatide works by activating GIP and GLP-1 receptors, two pathways involved in appetite regulation, digestion, insulin signaling, and blood-sugar control.

By influencing these pathways, tirzepatide can help reduce hunger, improve feelings of fullness, decrease food cravings, and support meaningful weight-management progress when combined with nutrition and lifestyle changes.

Glycine is an amino acid involved in normal metabolic and cellular processes and is included as part of the compounded formulation.

Treatment usually begins at a lower dose and may be increased gradually based on your tolerance, response, and treatment goals.

With consistent treatment, patients may experience:

• Reduced appetite
• Feeling full sooner and for longer
• Fewer food cravings
• Improved portion control
• Progressive weight loss over time
• Support for healthier blood-sugar and metabolic patterns

Results vary from person to person. Nutrition, physical activity, sleep, and consistency with treatment remain important parts of a successful weight-management program.

Before starting Tirzepatide + Glycine, your medical prescriber will review your health history, current medications, previous weight-management treatments, and treatment goals to determine whether it is appropriate for you.

Be sure to discuss any history of pancreatitis, gallbladder disease, significant digestive problems, kidney concerns, diabetes-related eye disease, or thyroid cancer, including a personal or family history of medullary thyroid carcinoma or MEN2.

Let your provider know if you are pregnant, breastfeeding, planning pregnancy, or taking medications that affect blood sugar or appetite.

Your dose may be increased gradually based on tolerance, response, and progress.

Prescription required.